Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer.

Elena CritselisMarta RavaMirari MarquezVasiliki LygirouDespoina ChatzicharalambousPanagiota LiapiRalph LichtinghagenKorbinian BrandLluís CecchiniAntonia VlahouNuria MalatsJerome Zoidakis

Published in: Proteomics. Clinical applications (2019)

SPARC diagnostic performance for detecting UBC appears insufficient for clinical implementation. In patients undergoing disease monitoring, SPARC is a promising prognostic marker for tumor relapse and/or progression, but is affected by hematuria.

Keyphrases

patients undergoing
primary care
healthcare
high throughput
quality improvement
ionic liquid
protein protein
fluorescent probe
amino acid